Pharm D Solutions, LLC recalls Tri-Mix Papaverine/Phentolamine/Alprostadil 150 mg/5 mg/50 mcg a) Injectable NDC 69699-1332-05 b) (LYO) Powder NDC 69699
Recalled November 7, 2018 · FDA recall D-0191-2019 · Pharm D Solutions
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
609 vials
Sold at
Nationwide
Description
Lack of Assurance of Sterility
Product
Tri-Mix Papaverine/Phentolamine/Alprostadil 150 mg/5 mg/50 mcg a) Injectable NDC 69699-1332-05 b) (LYO) Powder NDC 69699-1332-05, Pharm D Solutions, Houston, Texas
Manufacturer(s)
Pharm D Solutions, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →